Wade K. Self

Jul 2, 2024 | nature.com | Alfredo Iacoangeli |Simon D. Topp |Puja R Mehta |Naomi Limbachiya |Kelly Williams |Wade K. Self | +15 more

Correction to: Nature Communications https://doi.org/10.1038/s41467-022-34620-y, published online 12 November 2022The original version of this Article contained an error in Figure 4. Under the heading ‘Disease duration (months)’, all disease durations were reported as ‘disease duration’ rather than reporting the numerical value. The correct version now reports the disease duration in months instead of the original, incorrect ‘disease duration’.

Sep 4, 2023 | nature.com | Wade K. Self |David M. Holtzman

AbstractAlzheimer disease (AD) is the most common contributor to dementia in the world, but strategies that slow or prevent its clinical progression have largely remained elusive, until recently. This Review highlights the latest advances in biomarker technologies and therapeutic development to improve AD diagnosis and treatment.